| A Study to Evaluate the Safety, Tolerability, PK and PD of DA-1241 in Healthy Male Subjects and Subjects With T2DM (NCT03646721) | Dong-A ST Co., Ltd. | 2018-08-29 |
| Study in Healthy Subjects to Compare Two Tablet Formulations of Memantine (Ebixa®) in Fasted and Fed Conditions (NCT03670095) | H. Lundbeck A/S | 2018-08-28 |
| A Phase 1b/2a Study of the Safety and Pharmacokinetics of Rhu-plasma Gelsolin in Hospitalized Subjects With CAP (NCT03466073) | BioAegis Therapeutics Inc. | 2018-08-28 |
| Trial of eRapa in Prostate Cancer Patients (NCT03618355) | Rapamycin Holdings, Inc. dba Emtora Biosciences | 2018-08-28 |
| Cabozantinib in Combination With 13-cis-Retinoic Acid in Children With Relapsed or Refractory Solid Tumors (NCT03611595) | Peter Zage | 2018-08-28 |
| A Study to Investigate the Drug-drug Interactions Between ACT-541468 and Ethanol in Healthy Subjects (NCT03609775) | Idorsia Pharmaceuticals Ltd. | 2018-08-28 |
| Aldesleukin and Pembrolizumab in Treating Patients With Advanced or Metastatic Kidney Cancer (NCT03260504) | University of Washington | 2018-08-28 |
| A Study of Single and Multiple Ascending Doses of JNJ-61393215 in Healthy Participants (NCT03649997) | Janssen Research & Development, LLC | 2018-08-28 |
| Different Level of Single-dose and Multiple-dose Bilastine PK Study in Chinese Population (NCT03633760) | A.Menarini Asia-Pacific Holdings Pte Ltd | 2018-08-28 |
| A Study Evaluating the Safety and Activity of Pegylated Recombinant Human Arginase (BCT-100) (NCT03455140) | University of Birmingham | 2018-08-28 |
| Evaluate the Safety, Tolerability and Immunogenicity Study of GLS-5300 in Healthy Volunteers (NCT03721718) | GeneOne Life Science, Inc. | 2018-08-28 |
| Adoptive Cellular Therapy in Pediatric Patients With High-grade Gliomas (NCT03334305) | University of Florida | 2018-08-27 |
| A Phase 1/2, Study Evaluating the Safety, Tolerability, PK, and Efficacy of Sotorasib (AMG 510) in Subjects With Solid Tumors With a Specific KRAS Mutation (CodeBreaK 100) (NCT03600883) | Amgen | 2018-08-27 |
| This Study in Healthy People Tests Whether Taking a Low Strength of Empagliflozin, Linagliptin, and Metformin Together in 1 Pill is the Same as Taking Them in Separate Pills (NCT03629054) | Boehringer Ingelheim | 2018-08-27 |
| Durvalumab With or Without Tremelimumab in Resectable Locally Advanced Squamous Cell Carcinoma of the Oral Cavity (NCT03784066) | Universitaire Ziekenhuizen KU Leuven | 2018-08-27 |
| Nab-paclitaxel in Combination with Gemcitabine for Pediatric Relapsed and Refractory Solid Tumors (NCT03507491) | Emory University | 2018-08-27 |
| A Study Exploring the Safety and Tolerability of INCB081776 in Participants With Advanced Malignancies (NCT03522142) | Incyte Corporation | 2018-08-27 |
| Intraperitoneal MCY-M11 (Mesothelin-targeting CAR) for Treatment of Advanced Ovarian Cancer and Peritoneal Mesothelioma (NCT03608618) | MaxCyte, Inc. | 2018-08-27 |
| A Single and Multiple Dose Study of PF-05221304 in Healthy Japanese Adults (NCT03597217) | Pfizer | 2018-08-27 |
| Phase Ib of L-NMMA and Pembrolizumab (NCT03236935) | The Methodist Hospital Research Institute | 2018-08-27 |
| A Clinical Study to Assess the Efficacy and Safety of Dexamethasone Suspension for Cataract Surgery (NCT03687931) | iDrop, Inc. | 2018-08-26 |
| The PK/PD Study of SHR0532 Tablets in Healthy Subjects (NCT03645278) | Jiangsu HengRui Medicine Co., Ltd. | 2018-08-24 |
| A Double-Blind Single-Ascending Dose (SAD) and Multiple-Ascending Dose (MAD) Study to Investigate the Safety, Tolerability, and Pharmacokinetics of RO7049389 in Healthy Chinese Participants (NCT03570658) | Hoffmann-La Roche | 2018-08-24 |
| A Safety and Tolerability Study of RJX Drug Product in Healthy Participants (NCT03680105) | Reven Pharmaceuticals, Inc. | 2018-08-24 |
| Galunisertib and Capecitabine in Advanced Resistant TGF-beta Activated Colorectal Cancer (NCT03470350) | The Netherlands Cancer Institute | 2018-08-24 |
| Ibrutinib With Radiation and Temozolomide in Patients With Newly Diagnosed Glioblastoma (NCT03535350) | Case Comprehensive Cancer Center | 2018-08-24 |
| ADCT-602 in Treating Patients With Recurrent or Refractory B-cell Acute Lymphoblastic Leukemia (NCT03698552) | M.D. Anderson Cancer Center | 2018-08-24 |
| A Study to Investigate the Safety, Tolerability, Pharmacokinetic/Pharmacodynamic Characteristics, and Food Effect of HSG4112 (NCT04732988) | Glaceum | 2018-08-23 |
| Safety, Tolerability, and Pharmacokinetics of REGN5069 in Healthy Volunteers (NCT03645746) | Regeneron Pharmaceuticals | 2018-08-23 |
| Phase I/II Study of Hydroxychloroquine With Itraconazole With Biochemically Recurrent Prostate Cancer (NCT03513211) | St Vincent's Hospital, Sydney | 2018-08-23 |
| Lorlatinib Renal Impairment Study (NCT03542305) | Pfizer | 2018-08-23 |
| A Clinical Study of AL2846 Capsule Combined With Gemzar Injection in the Treatment of Advanced Pancreatic Cancer (NCT06278493) | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 2018-08-23 |
| Study of Venetoclax, a BCL2 Antagonist, for Patients With Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) (NCT03485547) | Dana-Farber Cancer Institute | 2018-08-23 |
| Copanlisib With Ibrutinib for Patients With Recurrent/ Refractory Primary Central Nervous System Lymphoma (PCNSL) (NCT03581942) | Memorial Sloan Kettering Cancer Center | 2018-08-23 |
| Study of Milademetan in Japanese Patients With Relapsed or Refractory Acute Myeloid Leukemia (AML) (NCT03671564) | Daiichi Sankyo Co., Ltd. | 2018-08-23 |
| Bioequivalence of TF3 and TF2 and Effect of Food on the PK of Tepotinib (NCT03629223) | Merck KGaA, Darmstadt, Germany | 2018-08-23 |
| Multiple Ascending Doses (MAD) of Anti-A Disintegrin and Metalloproteinase With Thrombospondin Motifs-5 (Anti-ADAMTS-5) Nanobody in Participants With Knee Osteoarthritis (OA) (NCT03583346) | Merck KGaA, Darmstadt, Germany | 2018-08-23 |
| Rivastigmine Bioequivalence Trial With Multiple Application of Transdermal Patches (9.5mg/24h) (NCT03659435) | SocraTec R&D GmbH | 2018-08-22 |
| IO102 With Pembrolizumab, With or Without Chemotherapy, as First-line Treatment of Metastatic NSCLC (NCT03562871) | IO Biotech | 2018-08-22 |
| MYPHISMO: MYB and PD-1 Immunotherapies Against Multiple Oncologies Trial (NCT03287427) | Peter MacCallum Cancer Centre, Australia | 2018-08-22 |
| A First-in-human, Proof of Concept Study of CPK850 in Patients With RLBP1 Retinitis Pigmentosa (NCT03374657) | Novartis Pharmaceuticals | 2018-08-22 |
| Impact of Acetazolamide in Reducing Referred Postoperative Pain (NCT04470843) | Medical College of Wisconsin | 2018-08-22 |
| Phase 1A Study of the Safety of KSP/QRH Dimer (NCT03643068) | University of Michigan | 2018-08-22 |
| A Phase I Study of SB26 in Healthy Volunteers (NCT03630627) | Samsung Bioepis Co., Ltd. | 2018-08-22 |
| Lesion Dosimetry With Iodine-124 in Metastatic Thyroid Carcinoma (NCT03647358) | Memorial Sloan Kettering Cancer Center | 2018-08-21 |
| PRS-343 in Combination With Atezolizumab in HER2-Positive Solid Tumors (NCT03650348) | Pieris Pharmaceuticals, Inc. | 2018-08-21 |
| A Study of Benzathine Benzylpenicillin Intramuscular Injection in Japanese Healthy Subjects (NCT03612557) | Pfizer | 2018-08-20 |
| Intra-anal Oxymetazoline in Healthy Adult Volunteers (NCT03529487) | RDD Pharma Ltd | 2018-08-20 |
| A Study to Evaluate the Appropriateness of the Voriconazole Dosing Regimen (NCT03760276) | Seoul National University Hospital | 2018-08-20 |
| Safety and Tolerability of the Ophthalmic Gel PRO-165 Versus Artelac® Nightime Gel (NCT03697876) | Laboratorios Sophia S.A de C.V. | 2018-08-20 |
| Pharmacokinetics and Safety Study of CTAP101 Capsules in Japanese and Non-Japanese Healthy Subjects and Non-Japanese Healthy Subjects (NCT03660800) | OPKO Health, Inc. | 2018-08-20 |
| CMV-MVA Triplex Vaccination of Stem Cell Donors in Preventing CMV Viremia in Participants With Allogeneic Transplant (NCT03560752) | City of Hope Medical Center | 2018-08-20 |
| Pharmacokinetic Study of Dexmedetomidine After Intra-Nasal and Buccal Dosing in Children (NCT03668951) | Children's Hospital Medical Center, Cincinnati | 2018-08-20 |
| Effect of Tepotinib on PK of CYP3A Substrate Midazolam (NCT03628339) | Merck KGaA, Darmstadt, Germany | 2018-08-20 |
| Hydroxychloroquine, Palbociclib, and Letrozole Before Surgery in Treating Patients With Estrogen Receptor Positive, HER2 Negative Breast Cancer (NCT03774472) | M.D. Anderson Cancer Center | 2018-08-20 |
| Abexinostat in Combination With Pembrolizumab in Patients With Advanced Solid Tumor Malignancies (NCT03590054) | Rahul Aggarwal | 2018-08-20 |
| Comparing of the Pharmacokinetic, Safety and Pharmacodynamic of QL1206 and Xgeva® in Healthy Adults (NCT03651947) | Qilu Pharmaceutical Co., Ltd. | 2018-08-20 |
| Mesenchymal Stem Cell Therapy for Liver Cirrhosis (NCT03626090) | Stem Med Pte. Ltd. | 2018-08-18 |
| A Study of LY3209590 in Japanese Participants With Type 2 Diabetes (NCT03603704) | Eli Lilly and Company | 2018-08-17 |
| Drug-Drug Interaction Study to Evaluate the Effect of PF-06865571 on Metformin Pharmacokinetics (NCT03593707) | Pfizer | 2018-08-17 |
| INCMGA00012 in Combination With Other Therapies in Patients With Advanced Solid Tumors (NCT03589651) | Incyte Corporation | 2018-08-17 |
| Research Study Comparing Different Tablets With the Study Medicine Semaglutide in Healthy Men (NCT03638778) | Novo Nordisk A/S | 2018-08-17 |
| A Study to Assess the Mass Balance Recovery and Metabolite Profile & Identification of [14C]-APX001 in Healthy Males (NCT04804059) | Basilea Pharmaceutica | 2018-08-17 |
| PK Study of Aripiprazole IM Depot for Chinese Patients With Schizophrenia (NCT03285503) | Otsuka Beijing Research Institute | 2018-08-17 |
| Metabolism and Pharmacokinetics of Primaquine Enantiomers in Human Volunteers Receiving a Seven Day Dose Regimen (NCT03934450) | University of Mississippi, Oxford | 2018-08-17 |
| LIPIDS-P Trial Phase I/II Trial (NCT03405870) | University of Florida | 2018-08-17 |
| Safety, Tolerability, Pharmacokinetics and Efficacy of AMG 397 in Subjects With Selected Relapsed or Refractory Hematological Malignancies (NCT03465540) | Amgen | 2018-08-17 |
| A Study of the Safety, Tolerability, and Pharmacokinetics of Orally Administered Venglustat and Itraconazole in Healthy Adult Male Participants (NCT06421714) | Genzyme, a Sanofi Company | 2018-08-16 |
| Glucophage® Extended Release (XR) 750 Milligram (mg) Indonesia Bioequivalence (BE) Study (NCT03583385) | Merck KGaA, Darmstadt, Germany | 2018-08-16 |
| A Clinical Study of PD-L1 Antibody ZKAB001（Drug Code） in Recurrent or Metastatic Cervical Cancer (NCT03676959) | Lee's Pharmaceutical Limited | 2018-08-16 |
| Daratumumab and Ibrutinib in Treating Patients With Symptomatic Chronic Lymphocytic Leukemia (NCT03447808) | Jennifer Woyach | 2018-08-16 |
| [Tc-99m]-RPI-087 as an Imaging Marker in Osteoarthritis of the Knee Compared to Healthy Volunteers (NCT03503825) | Reiley Pharmaceuticals Inc. | 2018-08-16 |
| A Study in Healthy People to Measure the Amount of BI 655130 in the Blood After Injecting Different Doses Into Different Parts of the Body (NCT03617835) | Boehringer Ingelheim | 2018-08-16 |
| H3N2 M2SR in Pediatric Population (NCT03553940) | National Institute of Allergy and Infectious Diseases (NIAID) | 2018-08-15 |
| Safety and Efficacy of Quizartinib in Children and Young Adults With Acute Myeloid Leukemia (AML), a Cancer of the Blood (NCT03793478) | Daiichi Sankyo | 2018-08-15 |
| Study of Anlotinib Plus Chemotherapy as the First-line Treatment in Patients With Advanced NSCLC (NCT03636685) | Chinese Academy of Medical Sciences | 2018-08-15 |
| Reducing Hippocampal Hyperactivity and Improving Cognition in Schizophrenia (NCT03034356) | VA Office of Research and Development | 2018-08-15 |
| The Effect of Sugammadex Versus Neostigmine During Neuromuscular Blockade Reversal (NCT03579589) | Ohio State University | 2018-08-15 |
| Treatment of Relapsed and/or Refractory AQP4-IgG Seropositive NMOSD by Tandem CAR T Cells Targeting CD19 and CD20 (NCT03605238) | Chinese PLA General Hospital | 2018-08-15 |
| Study of Cirmtuzumab and Paclitaxel for Metastatic or Locally Advanced, Unresectable Breast Cancer (NCT02776917) | Barbara Parker, MD | 2018-08-15 |
| COmbiNing Cutting and Drug-Eluting Balloon for Resistant Arteriovenous Fistula sTenOsis (CONCERTO) (NCT05961852) | Singapore General Hospital | 2018-08-15 |
| TEW-7197 with Paclitaxel for the Treatment of Metastatic Gastric Cancer (NCT03698825) | MedPacto, Inc. | 2018-08-15 |
| A Study of Avelumab, Binimetinib and Talazoparib in Patients With Locally Advanced or Metastatic RAS-mutant Solid Tumors (NCT03637491) | Pfizer | 2018-08-15 |
| Testing the Combination of Copanlisib, Nivolumab and Ipilimumab in Patients With Advanced Cancer and Lymphoma (NCT03502733) | National Cancer Institute (NCI) | 2018-08-14 |
| A Study in Healthy Volunteers to Investigate How Much Test Medicine [14C]-Uproleselan is Taken up by the Body When Administered Directly Into the Vein (IV) (NCT03606447) | GlycoMimetics Incorporated | 2018-08-14 |
| An Investigational Study of Experimental Medication BMS-986165 in Healthy Participants (NCT03660436) | Bristol-Myers Squibb | 2018-08-14 |
| An Investigational Study to Evaluate Experimental Medication BMS-986224 in Renally Impaired Participants (NCT03634969) | Bristol-Myers Squibb | 2018-08-14 |
| Memory-Enriched T Cells in Treating Patients With Recurrent or Refractory Grade III-IV Glioma (NCT03389230) | City of Hope Medical Center | 2018-08-14 |
| A Phase 1 Study of SHR2554 in Subjects With Relapsed or Refractory Mature Lymphoid Neoplasms (NCT03603951) | Jiangsu HengRui Medicine Co., Ltd. | 2018-08-14 |
| A Study of AK111 in Healthy Subjects (NCT03622021) | Akesobio Australia Pty Ltd | 2018-08-14 |
| A Study to Assess Safety, Tolerability, and Pharmacokinetics of MEDI0382 in Non-diabetic Obese Participants (NCT03625778) | MedImmune LLC | 2018-08-14 |
| A Phase1 Study of VIB9600 (NCT03621605) | Amgen | 2018-08-14 |
| Rucaparib and Nivolumab in Patients With Prostate or Endometrial Cancer (NCT03572478) | University of Chicago | 2018-08-14 |
| An Investigational Study to Evaluate the Effects of Experimental Medication BMS-986256 in Healthy Participants (NCT03634995) | Bristol-Myers Squibb | 2018-08-14 |
| Quantitative Mapping of Substantia Nigra Iron in Parkinson's Disease (Stages I-IV, REM Sleep Behavior Disorder) and Controls (NCT03675282) | Weill Medical College of Cornell University | 2018-08-14 |
| A Study of Ixazomib and Ibrutinib in Relapsed/Refractory Mantle Cell Lymphoma (NCT03323151) | PrECOG, LLC. | 2018-08-13 |
| A Trial of Ipatasertib in Combination With Atezolizumab (NCT03673787) | Institute of Cancer Research, United Kingdom | 2018-08-13 |
| A Study to Investigate the Safety, Tolerability, Food Effect, Pharmacokinetics and Pharmacodynamics of FOR-6219 (NCT03709420) | Forendo Pharma Ltd | 2018-08-13 |
| Venetoclax and Vincristine in Treating Patients With Relapsed or Refractory T-cell or B-cell Acute Lymphoblastic Leukemia (NCT03504644) | ECOG-ACRIN Cancer Research Group | 2018-08-13 |
| Drug-drug Interaction Trial With Tralokinumab in Moderate to Severe Atopic Dermatitis - ECZTRA 4 (NCT03556592) | LEO Pharma | 2018-08-13 |